Earnings calls

S H Kelkar & Co. concall ledger

Every earnings call for SHK — management tone, guidance, KPIs and promise tracking, quarter by quarter.

SHK · 5 transcripts · Chemicals · latest Q3 FY26

Q3 FY26Published 09 Feb 2026Call held 09 Feb 2026

SHK Q3 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹1,718 cr+10% YoYAdjusted EBITDA Margin13%Gross Margin42.4%

Consolidated Revenue (9M FY26) ₹1,718 cr (+10% YoY); Adjusted EBITDA Margin 13.0%; Gross Margin 42.4%. 9M FY26 consolidated revenue of ₹1,718 crore, reflecting 10% Y-o-Y growth.

Read full transcript & analysis

Q2 FY26Published 12 Nov 2025Call held 12 Nov 2025

SHK Q2 FY26 Earnings Call Transcript & Analysis

H1 FY26 Revenue Growth0.12 yoy+12% YoYH1 FY26 Investments in New Initiatives₹32 crQ2 FY26 Investments in New Initiatives₹17 crH1 FY26 Additional Insurance Costs₹7 crH1 FY26 Adjusted EBITDA Margin14.5%

H1 FY26 Revenue Growth 0.12 yoy (+12% YoY); H1 FY26 Investments in New Initiatives ₹32 cr; Q2 FY26 Investments in New Initiatives ₹17 cr. H1 FY26 consolidated revenue grew 12% year-on-year.

Read full transcript & analysis

Q4 FY25Published 27 May 2025Call held 27 May 2025

SHK Q4 FY25 Earnings Call Transcript & Analysis

EBITDA Margin15%

EBITDA Margin 15%. S H Kelkar & Co. reported a strong 15% revenue growth for the fiscal year FY25.

Read full transcript & analysis

Q3 FY25Published 21 Feb 2025Call held 21 Feb 2025

SHK Q3 FY25 Earnings Call Transcript & Analysis

Revenue₹1,556 cr+17% YoYEBITDA Margin17%Gross Margin44%Net Debt₹703 cr

Revenue ₹1,556 cr (+17% YoY); EBITDA Margin (ex-investments) 17%; Gross Margin (9M average) 44%. Consolidated revenues for 9M FY25 grew 17% year-on-year to ₹1,556 crore.

Read full transcript & analysis

Q2 FY25Published 26 Nov 2024Call held 26 Nov 2024

SHK Q2 FY25 Earnings Call Transcript & Analysis

H1 FY25 Revenue₹1,013 crH1 FY25 Adjusted EBITDA Margin16.8%H1 FY25 Reported EBITDA Margin15.81%Q2 European Segment Revenue Growth0.115 yoy+12% YoYH1 FY25 CAPEX₹47 cr

H1 FY25 Revenue ₹1,013 cr; H1 FY25 Adjusted EBITDA Margin 16.8%; H1 FY25 Reported EBITDA Margin 15.81%. H1 FY25 revenues reached Rs. 1,013 crore, driven by small/mid-sized customers and global MNC orders.

Read full transcript & analysis